Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1220 of 5804
-
Targeted drug lorlatinib tested in kids with rare brain tumors
Disease control Recruiting nowThe goal of this study is to determine the response of the study drug loratinib in treating children who are newly diagnosed high-grade glioma with a fusion in ALK or ROS1. It will also evaluate the safety of lorlatinib when given with chemotherapy or after radiation therapy.
Phase: EARLY_PHASE1 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New antibody combo could shield kids from rabies after bites
Prevention Recruiting nowThis observational study is an open-label, prospective, multi-center design. The goal is to evaluate the long-term clinical survival outcomes at 3 months and 1 year in individuals under 18 years of age with WHO Category III rabies exposure who have received real-world Post-Exposu…
Sponsor: Synermore Biologics (Suzhou) Co., Ltd. • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
Robot therapist quiets ringing ears in new study
Symptom relief CompletedGiven the limited evidence on digital cognitive behavioral therapy (CBT) for chronic subjective tinnitus, particularly interventions supported by large language models (LLMs), this two-arm, 30-day randomized controlled trial will aim to evaluate the efficacy, safety, and usabilit…
Phase: NA • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Silent brain infarcts may signal future cognitive trouble after hemorrhage
Knowledge-focused Recruiting nowThe goal of this clinical trial is to see if silent brain infarcts (SBIs), or stroke-like symptoms detectable during brain imaging, are a possible contributor to cognitive decline for patients diagnosed with spontaneous intracerebral hemorrhage (sICH), or blood clot in the brain.…
Sponsor: Rush University Medical Center • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Malaria drug could help fight dangerous virus in transplant patients
Disease control Recruiting nowThis study is a randomized, open-label, active comparator-controlled, dose-ranging trial of the efficacy and safety of IV artesunate in combination with IV GCV or oral VGCV and SOC treatment compared to GCV or VGCV monotherapy and SOC treatment in SOT recipients with clinically s…
Phase: PHASE2 • Sponsor: Amivas Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Virtual reality training may boost stroke recovery
Disease control Recruiting nowThis randomized controlled trial aims to compare the effects of augmented reality (AR) and virtual reality (VR)-assisted treadmill gait training on balance and walking in individuals with stroke, within the framework of the International Classification of Functioning, Disability …
Phase: NA • Sponsor: Ankara Yildirim Beyazıt University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Stem cell eye drops aim to heal stubborn corneal wounds
Disease control Recruiting nowIn this phase II randomized double-masked clinical trials, subjects with non-resolving corneal epithelial disease/defect (i.e., refractory to standard treatments for at least two weeks) will receive 8 weeks treatment of topical mesenchymal stem cell secretome or vehicle, with con…
Phase: PHASE2 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New glasses could slow Kids' worsening eyesight
Disease control Recruiting nowThis is a randomized, controlled, open-label, evaluator-blinded, multicenter, clinical trial of 12-months duration to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses in reducing the progression of juvenile myopia in children of Chi…
Phase: NA • Sponsor: SightGlass Vision, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Poop pills could tame IBD: new trial tests gut bacteria therapy
Disease control OngoingThis study enrolled 94 patients with UC or CD. Two groups received either 8-week intestinal bacterial transplant capsule therapy or biological therapy, respectively. The control group received biological therapy alone, while the experimental group received biological therapy comb…
Phase: NA • Sponsor: Shanghai 10th People's Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:12 UTC
-
AI-Powered stethoscope could spot hidden Lung-Heart condition
Diagnosis Recruiting nowThis prospective, observational study will evaluate whether synchronized heart sound (phonocardiogram, PCG) and three-lead electrocardiogram (ECG) recordings (entered as separate interventions in PRS, though collected together in practice) collected with the Eko CORE 500 can help…
Sponsor: Eko Devices, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Could a Nerve-Protecting vitamin pill boost vision recovery in blocked retina veins?
Disease control Recruiting nowRetinal vein occlusion (RVO), a common retinal vascular disease, is frequently treated with anti-vascular endothelial growth factor (anti-VEGF) agents as first-line therapy. However, anti-VEGF monotherapy lacks neuroprotective effects, primarily targets vascular leakage and neova…
Phase: PHASE4 • Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New procedure aims to zap nerves to fix slow heartbeat
Disease control Recruiting nowThis study adopts a strategy combining basic research with clinical investigation to systematically explore the therapeutic value of cardioneuroablation in the treatment of vagally-mediated bradycardia. The study design fully considers the complexity of the scientific question an…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New imaging showdown: can PSMA PET/CT beat MRI for prostate cancer detection?
Diagnosis CompletedProstate cancer is the most common malignancy among elderly men. With the routine use of prostate-specific antigen (PSA) testing since the 1980s, the incidence of prostate cancer has significantly increased. The diagnosis of prostate cancer is established through prostate biopsy,…
Sponsor: Fatih Sultan Mehmet Training and Research Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:08 UTC
-
Ear-Zap therapy could restore arm movement after stroke
Symptom relief Recruiting nowThe aim of this clinical trial is to determine if trans-auricular vagus nerve stimulation (taVNS) is effective in improving upper extremity function in stroke survivors. The primary objectives include: Investigating whether taVNS improves motor function in stroke survivors. The s…
Phase: NA • Sponsor: Universidade Federal de Pernambuco • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Could a common vitamin restore immunotherapy power after antibiotics?
Disease control Recruiting nowWhen bladder cancer patients are treated to mobilize their own immune system to fight the tumor, drugs that kill the bacteria can impair the effectiveness of the treatment. The purpose of this study is to find out if the common dietary supplement Vitamin B3 could allow drugs that…
Phase: PHASE1 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
AI-Powered running coach aims to predict and prevent shin splints and Runner's knee
Disease control CompletedThis study aims to identify biomechanical risk factors associated with common running-related injuries in recreational runners using machine learning analysis. It also aims to evaluate whether a precision exercise intervention based on these risk factors can improve injury-relate…
Phase: NA • Sponsor: Zeyi Zhang • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Blood test may tell which oral cancer patients need more chemo
Knowledge-focused Recruiting nowThe aim 1 of this trial is the development of the Circulating tumor cells (CTCs) definition of oral cancer minimal residual disease (MRD), and aim 2 is a prospective trial of oral cancer treatment. If this trial is successful, it is expected that it may be able to provide a stand…
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
New gout drug aims to beat allopurinol in major trial
Disease control Recruiting nowThe primary objective of this study is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 compared with allopurinol in adult participants with hyperuricemia associated with gout.
Phase: PHASE3 • Sponsor: Crystalys Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Engineered immune cells take on bladder cancer in early trial
Disease control Recruiting nowThis is a Phase I/II and multicenter study designed to evaluate the efficacy and safety of 4SCAR-T cells in participants with locally advanced or metastatic urothelial bladder cancer (UBC) who have no further treatment available.
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Could a simple pill stop lungs from scarring? new trial launches
Disease control Recruiting nowThis study will investigate whether the senicapoc drug can prevent the scarring from worsening in interstitial lung disease. Researchers will compare Senicapoc to a placebo (a look-alike substance that contains no drug) to see if Senicapoc works to prevent lung function worsenin…
Phase: PHASE2 • Sponsor: Vejle Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC